The present pregnant women living with hiv antiretroviral therapy coverage for pmtct in Kenya is 90%, a decrease of 9% (-9.1%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Kenya
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Kenya
PMTCT antiretroviral therapy coverage
More indicators for Kenya
Male unintentional poisoning
3.5
-0.1
(2019)
Female wasting in children
4%
-2.4%
(2022)
Female prevalence of HIV
1.7%
-0.2%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar54
+intl dollar5
(2021)
Birth registration
66.9%
+6.9%
(2014)
Contraceptive modern method prevalence
61.2%
+4.8%
(2020)
Kenya PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 90% | -9% |
| 2021 | 99% | 0% |
| 2020 | 99% | -1% |
| 2019 | 100% | +4% |
| 2018 | 96% | +11% |
| 2017 | 85% | -8% |
| 2016 | 93% | +2% |
| 2015 | 91% | +20% |
| 2014 | 71% | +10% |
| 2013 | 61% | +2% |
| 2012 | 59% | -13% |
| 2011 | 72% | +19% |
| 2010 | 53% | -30% |
| 2009 | 83% | +2% |
| 2008 | 81% | +21% |
| 2007 | 60% | +20% |
| 2006 | 40% | +18% |
| 2005 | 22% | +19% |
| 2004 | 3% | +3% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |